Compare Aventis Pharma with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs J.B.CHEMICALS - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA J.B.CHEMICALS SANOFI INDIA/
J.B.CHEMICALS
 
P/E (TTM) x 36.1 15.6 232.2% View Chart
P/BV x 6.3 2.1 294.5% View Chart
Dividend Yield % 1.4 0.5 251.6%  

Financials

 SANOFI INDIA   J.B.CHEMICALS
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
J.B.CHEMICALS
Mar-18
SANOFI INDIA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs6,840363 1,883.8%   
Low Rs4,630255 1,815.7%   
Sales per share (Unadj.) Rs1,203.1169.1 711.3%  
Earnings per share (Unadj.) Rs165.316.6 995.6%  
Cash flow per share (Unadj.) Rs209.923.4 896.2%  
Dividends per share (Unadj.) Rs84.002.00 4,200.0%  
Dividend yield (eoy) %1.50.6 226.3%  
Book value per share (Unadj.) Rs963.6172.5 558.6%  
Shares outstanding (eoy) m23.0383.57 27.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x4.81.8 260.9%   
Avg P/E ratio x34.718.6 186.4%  
P/CF ratio (eoy) x27.313.2 207.1%  
Price / Book Value ratio x6.01.8 332.2%  
Dividend payout %50.812.0 421.9%   
Avg Mkt Cap Rs m132,07825,827 511.4%   
No. of employees `0003.33.8 87.5%   
Total wages/salary Rs m4,0682,511 162.0%   
Avg. sales/employee Rs Th8,393.83,747.4 224.0%   
Avg. wages/employee Rs Th1,232.4665.7 185.1%   
Avg. net profit/employee Rs Th1,153.0367.8 313.5%   
INCOME DATA
Net Sales Rs m27,70814,135 196.0%  
Other income Rs m897366 245.2%   
Total revenues Rs m28,60514,501 197.3%   
Gross profit Rs m6,2352,178 286.2%  
Depreciation Rs m1,027570 180.3%   
Interest Rs m735 20.1%   
Profit before tax Rs m6,0981,940 314.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,292552 415.0%   
Profit after tax Rs m3,8061,387 274.4%  
Gross profit margin %22.515.4 146.0%  
Effective tax rate %37.628.5 132.0%   
Net profit margin %13.79.8 140.0%  
BALANCE SHEET DATA
Current assets Rs m15,92210,470 152.1%   
Current liabilities Rs m6,2352,749 226.8%   
Net working cap to sales %35.054.6 64.0%  
Current ratio x2.63.8 67.0%  
Inventory Days Days6455 115.3%  
Debtors Days Days2178 26.9%  
Net fixed assets Rs m7,5395,811 129.7%   
Share capital Rs m230167 137.6%   
"Free" reserves Rs m21,96214,248 154.1%   
Net worth Rs m22,19214,416 153.9%   
Long term debt Rs m00-   
Total assets Rs m29,83917,649 169.1%  
Interest coverage x872.156.6 1,541.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.90.8 115.9%   
Return on assets %12.88.1 158.6%  
Return on equity %17.29.6 178.2%  
Return on capital %27.513.7 200.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7,5876,164 123.1%   
Fx outflow Rs m7,1451,334 535.4%   
Net fx Rs m4424,829 9.2%   
CASH FLOW
From Operations Rs m3,7391,231 303.9%  
From Investments Rs m-731-208 351.3%  
From Financial Activity Rs m-1,972-595 331.3%  
Net Cashflow Rs m1,036427 242.6%  

Share Holding

Indian Promoters % 0.0 55.4 -  
Foreign collaborators % 60.4 0.3 20,133.3%  
Indian inst/Mut Fund % 14.4 3.4 424.8%  
FIIs % 14.6 3.9 374.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 37.0 28.4%  
Shareholders   15,184 30,437 49.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ORCHID PHARMA LTD  WYETH LTD  TORRENT PHARMA  ALEMBIC LTD  CIPLA  

Compare SANOFI INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Oct 18, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - PROCTER & GAMBLE HEALTH COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS